Research Article
BibTex RIS Cite

Special Virus Vaccines-2

Year 2012, Volume: 12 Issue: 2, 71 - 76, 01.02.2012

Abstract

The aim of immunization is to prevent the vaccine-preventable diseases particularlly in infants and children. There
are vaccines against diseases which are frequently detected in public but their vaccines are not in our current
immunization schedules.

The aim of immunization is to prevent the vaccine-preventable diseases particularlly in infants and children. There are vaccines against diseases which are frequently detected in public but their vaccines are not in our current immunization schedules.

References

  • 1. American Academy of Pediatrics. Varicella-zoster infections. In: Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2006. p.711
  • 2. Marin M, Güris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep. 2007;56(RR-4):1.
  • 3. Philip S. LaRussa and Mona Marin. Varicella-Zoster Virus Infections By Robert M. Kliegman, MD, Bonita M.D. Stanton, MD, Joseph St. Geme, Nina Schor and Richard E. Behrman, MD . Nelson textbook of pediatrics. 19th ed. Philadelphia. 2011;1104-1110
  • 4. The Pink Book: Course Textbook - 12th Edition, chapter 21
  • 5. CDC. Prevention of herpes zoster. Recommendations of the Advisory Committee on Immunization Practices. MMWR 2008;57(No.RR-5).
  • 6. The Pink Book: Course Textbook - 12th Edition, chapter 10
  • 7. Joura EA, Lancet 2007; 369: 1693-1702
  • 8. Villa LL, Ault KA,et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine. 2006 Jul 7;24(27- 28):5571-83.
  • 9. Andrew L. Susman et.al. HPV and Cervical Cancer Prevention Counseling With Younger Adolescents: Implications for Primary Care Ann Fam Med. 2007 July; 5 (4) : 298–304.
  • 10. Kahn JA. Vaccination as a Prevention Strategy for Human Papillomavirus related Diseases.J Adolesc Health 2005;37(6 Suppl):S10-16
  • 11. Olsson SE, et al Vaccine 2007; 25: 4931-9.
  • 12. CDC 2007 Report
  • 13. The Pink Book: Course Textbook - 12th Edition, chapter 11
  • 14. Snaken R. Control of Influenza. Public Health Policy.Vaccine 1999;17:61-63
  • 15. American Academy of Pediatrics, Policy Statement: Recommendation for influenza immunization of children. Pediatrics. 2004;113:1441-1447.
  • 16. Recommendations for Prevention and Control of Influenza in Children, 2011-2012 Committee on Infectious Diseases Pediatrics 2011;128;813
  • 17. CDC, Using live attenued influenza vaccine for prevention and control of influenza. MMWR 2003;52(No.RR-13):1-8.

Özel Virüs Aşıları – 2

Year 2012, Volume: 12 Issue: 2, 71 - 76, 01.02.2012

Abstract

Bağışıklamada amaç; toplumda, özellikle bebek ve çocuklarda aşı ile korunabilir hastalıkların önüne geçmektir. Rutin aşı takvimimizde olmayan ancak toplumda sık gördüğümüz hastalıklara karşı virus aşıları mevcuttur.Aşılama ile hastalıkların ortaya çıkması engellenerek, bu hastalıklardan kaynaklanan hastaneye yatış ve ölümlerin önüne geçilebilmektedir. Ülkemizde hepatit a, rotavirüs, suçiçeği, influenza ve human papilloma virüse karşı aşı mevcut olup rutin aşı takvimimizde bu aşılar uygulanmamaktadır. Oysa epidemiyolojik çalışmalar bu aşıların koruduğu hastalıkların da rutin aşı şemamızda ki hastalıklar kadar önemli olduğunu göstermektedir. Bu bölümde suçiçeği aşısı, grip aşısı ve human papilloma virüs aşıları anlatılacaktır

References

  • 1. American Academy of Pediatrics. Varicella-zoster infections. In: Red Book: 2006 Report of the Committee on Infectious Diseases, 27th ed, Pickering LK (Ed), American Academy of Pediatrics, Elk Grove Village, IL 2006. p.711
  • 2. Marin M, Güris D, Chaves SS, Schmid S, Seward JF, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC) MMWR Recomm Rep. 2007;56(RR-4):1.
  • 3. Philip S. LaRussa and Mona Marin. Varicella-Zoster Virus Infections By Robert M. Kliegman, MD, Bonita M.D. Stanton, MD, Joseph St. Geme, Nina Schor and Richard E. Behrman, MD . Nelson textbook of pediatrics. 19th ed. Philadelphia. 2011;1104-1110
  • 4. The Pink Book: Course Textbook - 12th Edition, chapter 21
  • 5. CDC. Prevention of herpes zoster. Recommendations of the Advisory Committee on Immunization Practices. MMWR 2008;57(No.RR-5).
  • 6. The Pink Book: Course Textbook - 12th Edition, chapter 10
  • 7. Joura EA, Lancet 2007; 369: 1693-1702
  • 8. Villa LL, Ault KA,et al. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18. Vaccine. 2006 Jul 7;24(27- 28):5571-83.
  • 9. Andrew L. Susman et.al. HPV and Cervical Cancer Prevention Counseling With Younger Adolescents: Implications for Primary Care Ann Fam Med. 2007 July; 5 (4) : 298–304.
  • 10. Kahn JA. Vaccination as a Prevention Strategy for Human Papillomavirus related Diseases.J Adolesc Health 2005;37(6 Suppl):S10-16
  • 11. Olsson SE, et al Vaccine 2007; 25: 4931-9.
  • 12. CDC 2007 Report
  • 13. The Pink Book: Course Textbook - 12th Edition, chapter 11
  • 14. Snaken R. Control of Influenza. Public Health Policy.Vaccine 1999;17:61-63
  • 15. American Academy of Pediatrics, Policy Statement: Recommendation for influenza immunization of children. Pediatrics. 2004;113:1441-1447.
  • 16. Recommendations for Prevention and Control of Influenza in Children, 2011-2012 Committee on Infectious Diseases Pediatrics 2011;128;813
  • 17. CDC, Using live attenued influenza vaccine for prevention and control of influenza. MMWR 2003;52(No.RR-13):1-8.
There are 17 citations in total.

Details

Primary Language Turkish
Journal Section Reviews
Authors

Selda Sivaslıoğlu This is me

Publication Date February 1, 2012
Published in Issue Year 2012 Volume: 12 Issue: 2

Cite

APA Sivaslıoğlu, S. (2012). Özel Virüs Aşıları – 2. Ankara Medical Journal, 12(2), 71-76.
AMA Sivaslıoğlu S. Özel Virüs Aşıları – 2. Ankara Med J. February 2012;12(2):71-76.
Chicago Sivaslıoğlu, Selda. “Özel Virüs Aşıları – 2”. Ankara Medical Journal 12, no. 2 (February 2012): 71-76.
EndNote Sivaslıoğlu S (February 1, 2012) Özel Virüs Aşıları – 2. Ankara Medical Journal 12 2 71–76.
IEEE S. Sivaslıoğlu, “Özel Virüs Aşıları – 2”, Ankara Med J, vol. 12, no. 2, pp. 71–76, 2012.
ISNAD Sivaslıoğlu, Selda. “Özel Virüs Aşıları – 2”. Ankara Medical Journal 12/2 (February 2012), 71-76.
JAMA Sivaslıoğlu S. Özel Virüs Aşıları – 2. Ankara Med J. 2012;12:71–76.
MLA Sivaslıoğlu, Selda. “Özel Virüs Aşıları – 2”. Ankara Medical Journal, vol. 12, no. 2, 2012, pp. 71-76.
Vancouver Sivaslıoğlu S. Özel Virüs Aşıları – 2. Ankara Med J. 2012;12(2):71-6.